Versartis Inc (NASDAQ:VSAR)

18.92
Delayed Data
As of Jul 06
 +4.30 / +29.41%
Today’s Change
14.13
Today|||52-Week Range
29.93
-15.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$427.9M

Company Description

Versartis, Inc. is an endocrine-focused biopharmaceutical company. It develops long-acting therapeutic proteins for the treatment of endocrine disorders. The company develops new therapeutic proteins utilizing the novel half-life extension technology XTEN. Versartis was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Redwood City, CA.

Contact Information

Versartis, Inc.
4200 Bohannon Drive
Menlo Park California 94025
P:(650) 963-8580
Investor Relations:

Employees

Shareholders

Individual stakeholders39.78%
Other institutional31.28%
Mutual fund holders28.26%

Top Executives

Jay P. ShepardPresident & Chief Executive Officer
Joshua T. BrummChief Financial Officer & Head-Investor Relations
Bert BakkerSenior Vice President-Medical Affairs
Shane M. WardSenior Vice President-Legal & Compliance
Paul B. WestbergSenior Vice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account